MSB 8.42% $1.03 mesoblast limited

Cell Therapy News/Articles, page-17826

  1. 15,592 Posts.
    lightbulb Created with Sketch. 5667
    The word is getting out there .... slowly .... now let me see a CHF partnership deal before we even get a response from the FDA - we don't have the funds to wait for a Jan 2025 FDA decision; run the CLBP trial on our own and cover ongoing costs no matter what the company or people on here claim about the 'cash runway' ... simples !


    @Mesoblast announced that the US @FDA has accepted its Biologics License Application resubmission for Ryoncil® in the treatment of children with steroid-refractory acute graft-versus-host disease.

    Learn more in the press release: https://bit.ly/4feJSWh


    https://x.com/MesenchymalCell/status/1816231658107842789
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.